Rose's Super Discount Drugs Revenue and Competitors
Estimated Revenue & Valuation
- Rose's Super Discount Drugs's estimated annual revenue is currently $11.3M per year.
- Rose's Super Discount Drugs's estimated revenue per employee is $201,000
Employee Data
- Rose's Super Discount Drugs has 56 Employees.
- Rose's Super Discount Drugs grew their employee count by 155% last year.
Rose's Super Discount Drugs's People
Name | Title | Email/Phone |
---|
Rose's Super Discount Drugs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $28.9M | 144 | 12% | N/A | N/A |
#2 | $5.6M | 28 | 4% | N/A | N/A |
#3 | $3.6M | 18 | -68% | N/A | N/A |
#4 | $63.5M | 316 | 5% | N/A | N/A |
#5 | $0.4M | 2 | -93% | N/A | N/A |
#6 | $7.8M | 39 | -13% | N/A | N/A |
#7 | $12.7M | 63 | 0% | N/A | N/A |
#8 | $11.3M | 56 | 155% | N/A | N/A |
What Is Rose's Super Discount Drugs?
About\nThe profession of pharmacy began with the independent pharmacist. A community pharmacist is an entrepreneur and small business owner. Customer service is the foundation of their business. Keeping their local community healthy is their number one priority.\n\n \n\nMississippi Independent Pharmacies Association was formed in 2002 to provide a unified voice for independently owned pharmacists in public policy discussions. The association was created by independent pharmacists and promotes independent, community pharmacies on a statewide and national level.\n\n \n\nMIPA is one of the premiere national associations with an aggressive political agenda to protect independent, community pharmacies. MIPA educates our state legislature, congressional leaders and citizens on the importance of
keywords:N/AN/A
Total Funding
56
Number of Employees
$11.3M
Revenue (est)
155%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 67 | 14% | N/A |
#2 | $15M | 81 | 9% | N/A |
#3 | $29.7M | 90 | 7% | N/A |
#4 | $22.2M | 101 | -26% | N/A |
#5 | $37.3M | 138 | 23% | N/A |